Duke is a member of the national Trial Innovation Network (TIN), an innovative collaboration addressing critical roadblocks in clinical research and accelerating the translation of novel interventions into life-saving therapies.
The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand, and innovate new ideas in the process of conducting clinical trials.
Why do multi-site research with the TIN?
The Trial Innovation Network streamlines the process, with a single IRB system, master contracting agreements, quality by design approaches, and a focus on evidence-based strategies to recruitment and patient engagement.
How do Duke investigators use the TIN?
Duke investigators can use the TIN to propose multi-site clinical trials and studies. Those interested in submitting proposals to the Trial Innovation Network should review the Proposal Submission Materials below and contact the Duke TIN Hub Liaison Team (email@example.com).
View guidelines, instructions and checklists to assist with submitting a proposal to the Trial Innovation Network. For more information about the Trial Innovation Network, please email the network or visit the Trial Innovation Network website.